Skip to main content
. Author manuscript; available in PMC: 2013 Aug 7.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 Mar 26;63(2):219–228. doi: 10.1007/s00280-008-0729-3

Table 4.

Relative metabolic rates

Treatment group Relative metabolic rate
MCF7WT control 2.53
MCF7WT trastuzumab 2.32
MCF7Her2 control 2.80
MCF7Her2 trastuzumab 2.41

See “Discussion” for details on how these values were calculated